TBIO (telesisbio.com) Nilai bisnis marang pendapatan

Telesis Bio, Inc. (TBIO) generates revenue through the sale of automated systems and consumables for DNA synthesis, which ensures moderate stability of cash flows. This EV/Revenue chart allows for an objective correlation between the business value and its sales, with serving as the current metric level. The integration of BioXp software closes the research cycle, while streamlined international reagent logistics guarantee a seamless supply chain.
Rincian metrik keuangan lan pasar Telesis Bio, Inc (TBIO)

DNA synthesis automation via the BioXp system accelerates pharmaceutical development, making the EV/Sales valuation of Telesis Bio, Inc. (TBIO) a key indicator of the scalability of its technological advantage. This ratio relates the total enterprise value, including debt, to revenue, allowing investors to determine the market premium paid per unit of income and identify the risk of asset overvaluation amid rising operating expenses.